9 Meters Biopharm

-$0.0123 (-2.57%) Today
+$0.029 (+6.22%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMTR and other ETFs, options, and stocks.

About NMTR

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs.

CEO
John Temperato
Employees
21
Headquarters
Raleigh, North Carolina
Founded
2012

NMTR Key Statistics

Market cap
120.74M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.67M
High today
$0.475
Low today
$0.4301
Open price
$0.4605
Volume
1.41M
52 Week high
$1.55
52 Week low
$0.3501

NMTR Earnings

-$0.06
-$0.04
-$0.02
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.04 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure